Structure

Physi-Chem Properties

Molecular Weight:  506.18
Volume:  490.888
LogP:  1.768
LogD:  1.192
LogS:  -2.622
# Rotatable Bonds:  9
TPSA:  172.21
# H-Bond Aceptor:  11
# H-Bond Donor:  5
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.182
Synthetic Accessibility Score:  4.654
Fsp3:  0.44
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.021
MDCK Permeability:  3.650739017757587e-05
Pgp-inhibitor:  0.107
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.977
20% Bioavailability (F20%):  0.984
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.12
Plasma Protein Binding (PPB):  85.0304183959961%
Volume Distribution (VD):  0.556
Pgp-substrate:  11.823121070861816%

ADMET: Metabolism

CYP1A2-inhibitor:  0.071
CYP1A2-substrate:  0.032
CYP2C19-inhibitor:  0.142
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.219
CYP2C9-substrate:  0.085
CYP2D6-inhibitor:  0.012
CYP2D6-substrate:  0.087
CYP3A4-inhibitor:  0.142
CYP3A4-substrate:  0.186

ADMET: Excretion

Clearance (CL):  1.521
Half-life (T1/2):  0.911

ADMET: Toxicity

hERG Blockers:  0.105
Human Hepatotoxicity (H-HT):  0.692
Drug-inuced Liver Injury (DILI):  0.334
AMES Toxicity:  0.218
Rat Oral Acute Toxicity:  0.413
Maximum Recommended Daily Dose:  0.893
Skin Sensitization:  0.864
Carcinogencity:  0.093
Eye Corrosion:  0.003
Eye Irritation:  0.039
Respiratory Toxicity:  0.18

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC281798

Natural Product ID:  NPC281798
Common Name*:   Kodemariosides A
IUPAC Name:   [(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2Z)-2-[(4S,5R)-4-hydroxy-5-(2-methylprop-1-enyl)-2-oxooxolan-3-ylidene]ethoxy]oxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  KRHXGSVJPFGCQY-PBPOHICXSA-N
Standard InCHI:  InChI=1S/C25H30O11/c1-13(2)11-17-20(28)16(24(32)35-17)9-10-33-25-23(31)22(30)21(29)18(36-25)12-34-19(27)8-5-14-3-6-15(26)7-4-14/h3-9,11,17-18,20-23,25-26,28-31H,10,12H2,1-2H3/b8-5+,16-9-/t17-,18-,20+,21-,22+,23-,25-/m1/s1
SMILES:  CC(=C[C@@H]1[C@H](/C(=C/CO[C@H]2[C@@H]([C@H]([C@@H]([C@@H](COC(=O)/C=C/c3ccc(cc3)O)O2)O)O)O)/C(=O)O1)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1088521
PubChem CID:   46833712
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0003002] Hydroxycinnamic acid esters
            • [CHEMONTID:0000465] Coumaric acid esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8538 Spiraea cantoniensis Species Rosaceae Eukaryota n.a. n.a. n.a. PMID[20329740]
NPO8538 Spiraea cantoniensis Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT671 Individual Protein Acidic alpha-glucosidase Rattus norvegicus Inhibition = 15.0 % PMID[481444]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC281798 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9466 High Similarity NPC220942
0.9365 High Similarity NPC45224
0.9365 High Similarity NPC471881
0.9365 High Similarity NPC173150
0.9365 High Similarity NPC156692
0.9365 High Similarity NPC471882
0.9365 High Similarity NPC35288
0.9313 High Similarity NPC470572
0.9274 High Similarity NPC52097
0.9194 High Similarity NPC11724
0.9141 High Similarity NPC225307
0.9134 High Similarity NPC61181
0.9134 High Similarity NPC471157
0.9113 High Similarity NPC476872
0.9062 High Similarity NPC106677
0.9062 High Similarity NPC103533
0.9055 High Similarity NPC83218
0.9055 High Similarity NPC126991
0.903 High Similarity NPC220936
0.903 High Similarity NPC31745
0.9023 High Similarity NPC472132
0.8984 High Similarity NPC252114
0.8939 High Similarity NPC254398
0.8931 High Similarity NPC219677
0.8931 High Similarity NPC478255
0.8923 High Similarity NPC469549
0.8915 High Similarity NPC288416
0.8872 High Similarity NPC471883
0.8872 High Similarity NPC169398
0.8864 High Similarity NPC473924
0.8841 High Similarity NPC63304
0.8797 High Similarity NPC28637
0.8797 High Similarity NPC114116
0.8788 High Similarity NPC138777
0.8788 High Similarity NPC225384
0.8788 High Similarity NPC46137
0.8788 High Similarity NPC254819
0.8788 High Similarity NPC235294
0.8788 High Similarity NPC246869
0.8779 High Similarity NPC229784
0.8779 High Similarity NPC477293
0.8779 High Similarity NPC477294
0.8779 High Similarity NPC253595
0.8741 High Similarity NPC471345
0.8722 High Similarity NPC473285
0.8714 High Similarity NPC143246
0.8714 High Similarity NPC475539
0.8714 High Similarity NPC119773
0.8714 High Similarity NPC474268
0.8702 High Similarity NPC232880
0.8676 High Similarity NPC469364
0.8676 High Similarity NPC65262
0.8676 High Similarity NPC101686
0.8643 High Similarity NPC475528
0.8633 High Similarity NPC478250
0.8633 High Similarity NPC152796
0.8633 High Similarity NPC475213
0.8633 High Similarity NPC293154
0.8626 High Similarity NPC476873
0.8613 High Similarity NPC226005
0.8593 High Similarity NPC471029
0.8583 High Similarity NPC282409
0.8583 High Similarity NPC469702
0.8582 High Similarity NPC471095
0.8582 High Similarity NPC471066
0.8582 High Similarity NPC473867
0.8582 High Similarity NPC473147
0.8571 High Similarity NPC296659
0.8571 High Similarity NPC202391
0.8571 High Similarity NPC194938
0.8548 High Similarity NPC313193
0.8529 High Similarity NPC263829
0.8519 High Similarity NPC215484
0.8519 High Similarity NPC164172
0.8516 High Similarity NPC476445
0.8516 High Similarity NPC469548
0.8516 High Similarity NPC476448
0.8511 High Similarity NPC210330
0.85 High Similarity NPC186296
0.8496 Intermediate Similarity NPC295970
0.8489 Intermediate Similarity NPC154262
0.8489 Intermediate Similarity NPC159387
0.8489 Intermediate Similarity NPC137501
0.8489 Intermediate Similarity NPC7518
0.8478 Intermediate Similarity NPC321184
0.8478 Intermediate Similarity NPC321638
0.8478 Intermediate Similarity NPC171134
0.8478 Intermediate Similarity NPC49597
0.8478 Intermediate Similarity NPC328273
0.8467 Intermediate Similarity NPC157554
0.8456 Intermediate Similarity NPC34293
0.8456 Intermediate Similarity NPC886
0.8456 Intermediate Similarity NPC474895
0.8456 Intermediate Similarity NPC287597
0.8451 Intermediate Similarity NPC212808
0.844 Intermediate Similarity NPC77922
0.844 Intermediate Similarity NPC251062
0.844 Intermediate Similarity NPC184464
0.844 Intermediate Similarity NPC473281
0.8433 Intermediate Similarity NPC469705
0.8433 Intermediate Similarity NPC470122
0.8433 Intermediate Similarity NPC17968
0.8429 Intermediate Similarity NPC469623
0.8429 Intermediate Similarity NPC296643
0.8429 Intermediate Similarity NPC148080
0.8421 Intermediate Similarity NPC158673
0.8421 Intermediate Similarity NPC198487
0.8414 Intermediate Similarity NPC474620
0.8413 Intermediate Similarity NPC148055
0.8413 Intermediate Similarity NPC175771
0.8406 Intermediate Similarity NPC476376
0.8403 Intermediate Similarity NPC96599
0.8394 Intermediate Similarity NPC476870
0.8369 Intermediate Similarity NPC242756
0.8345 Intermediate Similarity NPC89105
0.8345 Intermediate Similarity NPC100389
0.8345 Intermediate Similarity NPC64141
0.8345 Intermediate Similarity NPC68092
0.8345 Intermediate Similarity NPC476383
0.8345 Intermediate Similarity NPC35097
0.8345 Intermediate Similarity NPC240592
0.8345 Intermediate Similarity NPC117346
0.8345 Intermediate Similarity NPC472350
0.8345 Intermediate Similarity NPC81515
0.8345 Intermediate Similarity NPC197316
0.8333 Intermediate Similarity NPC166180
0.8333 Intermediate Similarity NPC123704
0.8333 Intermediate Similarity NPC120728
0.8333 Intermediate Similarity NPC37468
0.8322 Intermediate Similarity NPC291153
0.8322 Intermediate Similarity NPC320734
0.831 Intermediate Similarity NPC196063
0.831 Intermediate Similarity NPC110063
0.831 Intermediate Similarity NPC300894
0.831 Intermediate Similarity NPC297342
0.831 Intermediate Similarity NPC296954
0.831 Intermediate Similarity NPC141455
0.8299 Intermediate Similarity NPC183536
0.8299 Intermediate Similarity NPC87403
0.8299 Intermediate Similarity NPC34965
0.8284 Intermediate Similarity NPC146540
0.8276 Intermediate Similarity NPC478242
0.8276 Intermediate Similarity NPC478234
0.8273 Intermediate Similarity NPC78363
0.8273 Intermediate Similarity NPC260425
0.8273 Intermediate Similarity NPC469696
0.8271 Intermediate Similarity NPC233559
0.8271 Intermediate Similarity NPC147192
0.8264 Intermediate Similarity NPC473149
0.8261 Intermediate Similarity NPC70680
0.8261 Intermediate Similarity NPC233350
0.8261 Intermediate Similarity NPC182217
0.8261 Intermediate Similarity NPC185778
0.8255 Intermediate Similarity NPC475378
0.8254 Intermediate Similarity NPC157338
0.8252 Intermediate Similarity NPC83743
0.8252 Intermediate Similarity NPC262182
0.8252 Intermediate Similarity NPC287615
0.8252 Intermediate Similarity NPC216819
0.8244 Intermediate Similarity NPC471067
0.8244 Intermediate Similarity NPC469927
0.8239 Intermediate Similarity NPC105005
0.8239 Intermediate Similarity NPC40305
0.8235 Intermediate Similarity NPC476407
0.8231 Intermediate Similarity NPC106818
0.8231 Intermediate Similarity NPC203664
0.8227 Intermediate Similarity NPC46644
0.8227 Intermediate Similarity NPC80098
0.8227 Intermediate Similarity NPC476385
0.8227 Intermediate Similarity NPC476377
0.8227 Intermediate Similarity NPC47471
0.8227 Intermediate Similarity NPC134405
0.8222 Intermediate Similarity NPC214246
0.8219 Intermediate Similarity NPC12006
0.8219 Intermediate Similarity NPC69367
0.8214 Intermediate Similarity NPC62800
0.8214 Intermediate Similarity NPC205195
0.8214 Intermediate Similarity NPC324262
0.8207 Intermediate Similarity NPC473138
0.8207 Intermediate Similarity NPC28776
0.8201 Intermediate Similarity NPC186418
0.8194 Intermediate Similarity NPC229505
0.8188 Intermediate Similarity NPC68517
0.8188 Intermediate Similarity NPC106406
0.8182 Intermediate Similarity NPC471028
0.8182 Intermediate Similarity NPC236981
0.8182 Intermediate Similarity NPC178449
0.8182 Intermediate Similarity NPC470907
0.8182 Intermediate Similarity NPC232454
0.8169 Intermediate Similarity NPC222433
0.8169 Intermediate Similarity NPC265648
0.8169 Intermediate Similarity NPC157816
0.8169 Intermediate Similarity NPC65833
0.8169 Intermediate Similarity NPC140502
0.8168 Intermediate Similarity NPC55608
0.8163 Intermediate Similarity NPC158546
0.8163 Intermediate Similarity NPC289021
0.8158 Intermediate Similarity NPC477627
0.8156 Intermediate Similarity NPC202700
0.8156 Intermediate Similarity NPC475530

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC281798 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8345 Intermediate Similarity NPD7266 Discontinued
0.774 Intermediate Similarity NPD6190 Approved
0.763 Intermediate Similarity NPD1091 Approved
0.7613 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD9545 Approved
0.755 Intermediate Similarity NPD1653 Approved
0.7535 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6559 Discontinued
0.7462 Intermediate Similarity NPD969 Suspended
0.7453 Intermediate Similarity NPD3818 Discontinued
0.7378 Intermediate Similarity NPD7685 Pre-registration
0.7361 Intermediate Similarity NPD230 Phase 1
0.7315 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD4628 Phase 3
0.7287 Intermediate Similarity NPD1358 Approved
0.7285 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD3764 Approved
0.726 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD37 Approved
0.7239 Intermediate Similarity NPD7228 Approved
0.7234 Intermediate Similarity NPD5647 Approved
0.7233 Intermediate Similarity NPD6234 Discontinued
0.7229 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD4380 Phase 2
0.7215 Intermediate Similarity NPD4966 Approved
0.7215 Intermediate Similarity NPD4967 Phase 2
0.7215 Intermediate Similarity NPD4965 Approved
0.7197 Intermediate Similarity NPD8455 Phase 2
0.7195 Intermediate Similarity NPD7054 Approved
0.7195 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD9493 Approved
0.717 Intermediate Similarity NPD7075 Discontinued
0.7152 Intermediate Similarity NPD7074 Phase 3
0.7152 Intermediate Similarity NPD7472 Approved
0.7143 Intermediate Similarity NPD7097 Phase 1
0.7108 Intermediate Similarity NPD6797 Phase 2
0.7103 Intermediate Similarity NPD6233 Phase 2
0.7095 Intermediate Similarity NPD7033 Discontinued
0.7083 Intermediate Similarity NPD8312 Approved
0.7083 Intermediate Similarity NPD8313 Approved
0.7077 Intermediate Similarity NPD3134 Approved
0.7066 Intermediate Similarity NPD7251 Discontinued
0.7059 Intermediate Similarity NPD6799 Approved
0.7032 Intermediate Similarity NPD5403 Approved
0.7029 Intermediate Similarity NPD1357 Approved
0.7025 Intermediate Similarity NPD6801 Discontinued
0.7024 Intermediate Similarity NPD7808 Phase 3
0.7021 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD1652 Phase 2
0.7 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.6994 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6981 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6978 Remote Similarity NPD5126 Approved
0.6978 Remote Similarity NPD5125 Phase 3
0.6959 Remote Similarity NPD6653 Approved
0.6954 Remote Similarity NPD2424 Discontinued
0.6937 Remote Similarity NPD5402 Approved
0.6933 Remote Similarity NPD2935 Discontinued
0.6923 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6918 Remote Similarity NPD6798 Discontinued
0.6918 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6903 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6903 Remote Similarity NPD5401 Approved
0.6894 Remote Similarity NPD3882 Suspended
0.6894 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6892 Remote Similarity NPD1933 Approved
0.6892 Remote Similarity NPD6355 Discontinued
0.6883 Remote Similarity NPD5058 Phase 3
0.6879 Remote Similarity NPD3705 Approved
0.6879 Remote Similarity NPD422 Phase 1
0.6875 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4062 Phase 3
0.687 Remote Similarity NPD5048 Discontinued
0.6864 Remote Similarity NPD7240 Approved
0.6855 Remote Similarity NPD7411 Suspended
0.6849 Remote Similarity NPD3027 Phase 3
0.6842 Remote Similarity NPD1549 Phase 2
0.6831 Remote Similarity NPD9717 Approved
0.6829 Remote Similarity NPD7199 Phase 2
0.6821 Remote Similarity NPD1551 Phase 2
0.6813 Remote Similarity NPD1934 Approved
0.6806 Remote Similarity NPD1203 Approved
0.6797 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6795 Remote Similarity NPD2534 Approved
0.6795 Remote Similarity NPD2532 Approved
0.6795 Remote Similarity NPD2533 Approved
0.6792 Remote Similarity NPD6599 Discontinued
0.6791 Remote Similarity NPD2067 Discontinued
0.6781 Remote Similarity NPD6832 Phase 2
0.6779 Remote Similarity NPD447 Suspended
0.6779 Remote Similarity NPD4340 Discontinued
0.6779 Remote Similarity NPD5124 Phase 1
0.6779 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6776 Remote Similarity NPD6002 Phase 3
0.6776 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6776 Remote Similarity NPD6004 Phase 3
0.6776 Remote Similarity NPD6005 Phase 3
0.6776 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6776 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6776 Remote Similarity NPD1552 Clinical (unspecified phase)
0.677 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6765 Remote Similarity NPD7843 Approved
0.6753 Remote Similarity NPD8166 Discontinued
0.6736 Remote Similarity NPD3225 Approved
0.6735 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6732 Remote Similarity NPD970 Clinical (unspecified phase)
0.6728 Remote Similarity NPD3817 Phase 2
0.6726 Remote Similarity NPD3751 Discontinued
0.6718 Remote Similarity NPD6647 Phase 2
0.6716 Remote Similarity NPD2684 Approved
0.6716 Remote Similarity NPD74 Approved
0.6716 Remote Similarity NPD9266 Approved
0.6713 Remote Similarity NPD9269 Phase 2
0.6712 Remote Similarity NPD5736 Approved
0.6712 Remote Similarity NPD9494 Approved
0.6711 Remote Similarity NPD1240 Approved
0.6707 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6707 Remote Similarity NPD6166 Phase 2
0.6707 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6691 Remote Similarity NPD694 Clinical (unspecified phase)
0.669 Remote Similarity NPD6362 Approved
0.669 Remote Similarity NPD3847 Discontinued
0.6686 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2801 Approved
0.6667 Remote Similarity NPD7819 Suspended
0.6647 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6645 Remote Similarity NPD3400 Discontinued
0.6645 Remote Similarity NPD2799 Discontinued
0.6645 Remote Similarity NPD1510 Phase 2
0.6644 Remote Similarity NPD520 Approved
0.6643 Remote Similarity NPD5536 Phase 2
0.6643 Remote Similarity NPD1535 Discovery
0.6642 Remote Similarity NPD9264 Approved
0.6642 Remote Similarity NPD9267 Approved
0.6642 Remote Similarity NPD290 Approved
0.6642 Remote Similarity NPD9263 Approved
0.6629 Remote Similarity NPD6535 Approved
0.6629 Remote Similarity NPD6534 Approved
0.6625 Remote Similarity NPD7458 Discontinued
0.6625 Remote Similarity NPD3455 Phase 2
0.6623 Remote Similarity NPD1607 Approved
0.662 Remote Similarity NPD1778 Approved
0.6619 Remote Similarity NPD7157 Approved
0.6618 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6612 Remote Similarity NPD7435 Discontinued
0.6608 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6601 Remote Similarity NPD9570 Approved
0.66 Remote Similarity NPD1612 Clinical (unspecified phase)
0.66 Remote Similarity NPD4060 Phase 1
0.66 Remote Similarity NPD1613 Approved
0.6597 Remote Similarity NPD1481 Phase 2
0.6596 Remote Similarity NPD1894 Discontinued
0.6594 Remote Similarity NPD1241 Discontinued
0.6587 Remote Similarity NPD6232 Discontinued
0.6587 Remote Similarity NPD3787 Discontinued
0.6585 Remote Similarity NPD7768 Phase 2
0.6582 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6576 Remote Similarity NPD8320 Phase 1
0.6576 Remote Similarity NPD8319 Approved
0.6575 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6575 Remote Similarity NPD2797 Approved
0.6573 Remote Similarity NPD3496 Discontinued
0.6571 Remote Similarity NPD8434 Phase 2
0.6571 Remote Similarity NPD8150 Discontinued
0.6562 Remote Similarity NPD2934 Approved
0.6562 Remote Similarity NPD2933 Approved
0.656 Remote Similarity NPD689 Discontinued
0.6549 Remote Similarity NPD9268 Approved
0.6547 Remote Similarity NPD690 Clinical (unspecified phase)
0.6547 Remote Similarity NPD2629 Approved
0.6545 Remote Similarity NPD3749 Approved
0.6543 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6538 Remote Similarity NPD6779 Approved
0.6538 Remote Similarity NPD6781 Approved
0.6538 Remote Similarity NPD6780 Approved
0.6538 Remote Similarity NPD6782 Approved
0.6538 Remote Similarity NPD6776 Approved
0.6538 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6538 Remote Similarity NPD6778 Approved
0.6538 Remote Similarity NPD3750 Approved
0.6538 Remote Similarity NPD2575 Approved
0.6538 Remote Similarity NPD6777 Approved
0.6536 Remote Similarity NPD5588 Approved
0.6533 Remote Similarity NPD6663 Approved
0.6531 Remote Similarity NPD1019 Discontinued
0.6529 Remote Similarity NPD7799 Discontinued
0.6527 Remote Similarity NPD8127 Discontinued
0.6524 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6519 Remote Similarity NPD7699 Phase 2
0.6519 Remote Similarity NPD7700 Phase 2
0.6519 Remote Similarity NPD4357 Discontinued
0.6512 Remote Similarity NPD2860 Approved
0.6512 Remote Similarity NPD2859 Approved
0.651 Remote Similarity NPD7095 Approved
0.6509 Remote Similarity NPD7852 Clinical (unspecified phase)
0.65 Remote Similarity NPD920 Approved
0.6494 Remote Similarity NPD2240 Approved
0.6494 Remote Similarity NPD2239 Approved
0.6494 Remote Similarity NPD2796 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data